Osteosarcoma of bone
|
0.100 |
Biomarker
|
disease |
BEFREE |
Interleukin-1β/nuclear factor-κB signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis.
|
30977354 |
2019 |
Osteosarcoma of bone
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our results show that microglia in the spinal cord presented increased M1 polarization and decreased M2 polarization, while overproduction of IL-1β and inhibited expression of IL-10 was detected during bone cancer pain development.
|
29882480 |
2018 |
Osteosarcoma of bone
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
IL-1β-induced NF-κB activation down-regulates miR-506 expression to promotes osteosarcoma cell growth through JAG1.
|
28926924 |
2017 |
Osteosarcoma of bone
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, administration of berberine is capable of reducing the expression of caspase-1 and IL-1β in osteosarcoma cells and inhibiting the growth of tumor cells.
|
28000894 |
2017 |
Osteosarcoma of bone
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hence, the regulation of IL-1β/NF-κB/miR-376c/TGFA signaling in OS might present a promising strategy for the treatment of OS.
|
29441940 |
2017 |
Osteosarcoma of bone
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to investigate the association between IL-1B gene polymorphisms and osteosarcoma risk in Chinese Han patients.
|
24878968 |
2014 |
Osteosarcoma of bone
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Tumor necrosis factor-α, interleukin-1β and LPS enhanced osteosarcoma U2OS MMP-9 secretion but had no effect on MMP-2 secretion.
|
24190483 |
2014 |
Osteosarcoma of bone
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We examined the effect of IL-1 on FGF-2 mRNA and protein expression in human osteosarcoma MG-63 osteoblasts, normal human osteoblasts (NHOB), and osteoblasts from osteoarthritic patients (F2 and F13).
|
11485304 |
2001 |
Osteosarcoma of bone
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study we analyzed the effects of IL-1 on the intracellular distribution of PI3-kinase in wild-type Saos-2 human osteosarcoma cells, and in cell clones overexpressing type I IL-1 receptor (IL-1RI).
|
9973598 |
1999 |
Osteosarcoma of bone
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
This study examines the effects of IL-1 on PGHS-2 mRNA expression in human osteosarcoma MG-63 cells, the human osteoblast-like initial transfectant (HOBIT) cell line, and primary human osteoblastic (HOB) cells.
|
9661070 |
1998 |
Osteosarcoma of bone
|
0.100 |
Biomarker
|
disease |
BEFREE |
Recombinant human IL-1 beta inhibits human osteosarcoma cell proliferation, stimulates integrin expression, and induces alkaline phosphatase activity, a marker of osteoinductive and osteoblastic phenotype.
|
2786815 |
1989 |
Osteosarcoma of bone
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These data indicate that the beta 1 integrin family of cell surface receptors is a target for regulation by IL-1 beta, which also regulates cell proliferation and the expression of the osteoblastic phenotype in human osteosarcoma cells.
|
2521862 |
1989 |
Osteosarcoma of bone
|
0.100 |
Biomarker
|
disease |
BEFREE |
A factor that promotes the growth of certain B cell hybridomas and of plasmacytomas is shown to be produced by normal human fibroblasts and by a line of human osteosarcoma cells (MG-63) after treatment with IL-1 or TNF.
|
3493322 |
1987 |